Recent advancements in blood testing are facilitating the early detection of Alzheimer’s disease among patients with Down syndrome, offering a less invasive alternative to traditional diagnostic methods.
Researchers at UCL have utilized artificial intelligence to identify effective treatment combinations for patients with locally advanced rectal cancer, potentially improving survival rates.